Isis will provide Biogazelle with access to its antisense platform for the large-scale validation of therapeutic lncRNA targets from Biogazelle's target identification pipeline.
The accreditation is for the Belgian firm's mRNA, miRNA, and long non-coding RNA expression services.
NEW YORK (GenomeWeb) — Biogazelle said today that it has received a €2 million ($2.5 million) investment from Qbic Arkiv Fund, Foundation Majoie, and SOFI (Spin-Off Financing Instrument).
Core Life Sciences has signed a deal with Biogazelle that lets that company distribute qbase+, Core's software for analyzing qPCR data, in California.
Core Life Sciences said today that it has partnered with Belgium's Biogazelle to distribute its qbase+ qPCR software in California.
NEW YORK (GenomeWeb News) – Core Life Sciences announced this week that it and Biogazelle have reached an agreement to distribute Biogazelle's qbase+ software in California.
Belgium's Flanders Institute for Biotechnology, VIB, has licensed Biogazelle’s qbase+ software to support its real time PCR-based research projects.
BITS, the bioinformatics training and service facility of Belgium's Vlaams Instituut voor Biotechnologie, or VIB, will use Biogazelle's qbase+ software for PCR analysis, Biogazelle said this week.
Bio-Rad this week introduced qPCR assays and panels that have been wet-lab validated to meet the minimum information for publication of quantitative real-time PCR experiments, or MIQE, guidelines.
The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.
Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.
The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.
In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.